VINGLYN M 500MG (Metformin (500mg) + Vildagliptin (50mg))

Vinglyn M 500 mg Tablet is a combination medication that includes Vildagliptin, a DPP-4 inhibitor, and Metformin, classified as a biguanide, making it an effective treatment for managing type 2 diabetes mellitus. This condition, previously referred to as “non-insulin-dependent diabetes mellitus” or “maturity-onset diabetes,” occurs when the body either fails to produce adequate insulin or when the insulin available does not function effectively. It can also arise from an overproduction of glucagon, another hormone that raises blood sugar levels. Insulin is crucial for lowering blood sugar, particularly post-meals, while Vinglyn M works by enhancing insulin production from the pancreas and reducing glucagon levels, ultimately helping to control blood sugar levels. However, it is important to continue adhering to prescribed dietary and exercise regimens while taking Vinglyn M 500 mg Tablet, as it is not a substitute for insulin therapy and is not suitable for treating type 1 diabetes or diabetic ketoacidosis. For optimal absorption and to minimize gastrointestinal discomfort, it is recommended to take this medication with food, maintaining a consistent daily schedule. Dosage should be determined by a healthcare professional, as it may need adjustments based on individual health conditions. A common side effect is hypoglycemia, which may manifest as dizziness, sweating, and increased hunger, among other symptoms. To avoid such occurrences, it is advisable not to skip meals and to carry a source of sugar if needed. Discontinuing Vinglyn M 500 mg Tablet without medical consultation can lead to fluctuations in blood sugar levels, potentially resulting in serious complications such as vision loss, kidney impairment, or nerve damage. This medication should not be used by individuals with type 1 diabetes or significant kidney or liver diseases. Patients should inform their healthcare provider of any existing heart conditions or plans for pregnancy or breastfeeding prior to treatment.